Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen

Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen

US Patent 9839685 · Granted Dec 12, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nanoemulsion compositions for preventing, suppressing or eliminating allergic an2025
Nanoemulsion compositions for preventing, suppressing or eliminating allergic an2025
Vaccine for the prevention and treatment of C. difficile infections and the use 2025
Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration2024
Nanoemulsion compositions for preventing, suppressing or eliminating allergic an2023
Nanoemulsion compositions for preventing, suppressing or eliminating allergic an2023
Adjuvant compositions2021
Herpes simplex virus nanoemulsion vaccine2021
Cancer vaccine compositions and methods of using the same2021
Cancer vaccine compositions and methods of using the same2021
Nanoemulsion compositions for preventing, suppressing or eliminating allergic an2021
Nanoemulsion compositions for preventing, suppressing or eliminating allergic an2021